Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014
Cash flows from operating activities:
Net loss	$ (5,469)	$ (5,498)
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustment to gain on sale of Portamedic	0	150
Depreciation and amortization	873	652
Amortization of debt discount	244	0
Amortization of deferred financing fees	280	177
Provision for bad debt expense	26	62
Share-based compensation expense	193	373
Loss on disposal of fixed assets and other	0	35
Change in assets and liabilities:
Accounts receivable	(1,667)	1,819
Inventories	247	22
Other assets	(340)	47
Accounts payable, accrued expenses and other liabilities	514	982
Net cash used in operating activities	(5,099)	(1,179)
Cash flows from investing activities:
Capital expenditures	(355)	(423)
Acquisition of Accountable Health Solutions	(4,000)	0
Proceeds from the sale of Portamedic	0	743
Net cash (used in) provided by investing activities	(4,355)	320
Cash flows from financing activities:
Borrowings under credit facility	1,000	0
Payments under credit facility	(151)	0
Proceeds from issuance of Term Loan	5,000	0
Payments on capital lease obligations	0	(2)
Proceeds related to the exercise of stock options	23	28
Debt financing fees	(377)	0
Net cash provided by financing activities	5,495	26
Net decrease in cash and cash equivalents	(3,959)	(833)
Cash and cash equivalents at beginning of period	5,201	3,970
Cash and cash equivalents at end of period	1,242	3,137
Supplemental disclosure of non-cash investing activities:
Fixed assets vouchered but not paid	76	67
Debt financing fees vouchered but not paid	500	0
Supplemental disclosure of non-cash financing activities:
Issuance of common stock in connection with the Acquisition	3,000	0
Supplemental disclosure of cash paid during period for:
Income taxes	$ 0	$ 0